HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus HLA-Matched Unrelated Donor Transplantation for Myelodysplastic Syndrome

被引：0

作者：

Nakaya, Yosuke ^{[1
]}

Koh, Hideo ^{[2
]}

Konuma, Takaaki ^{[3
]}

Shimomura, Yoshimitsu ^{[4
,5
]}

Ishiyama, Ken ^{[6
]}

Itonaga, Hidehiro ^{[7
]}

Hino, Masayuki ^{[1
]}

Doki, Noriko ^{[8
]}

Nishida, Tetsuya ^{[9
]}

Ohigashi, Hiroyuki ^{[10
]}

Matsuoka, Ken-ichi ^{[11
]}

Kanda, Yoshinobu ^{[12
]}

Maruyama, Yumiko ^{[13
]}

Sawa, Masashi ^{[14
]}

Eto, Tetsuya ^{[15
]}

Hiramoto, Nobuhiro ^{[4
]}

Fukuda, Takahiro ^{[16
]}

Atsuta, Yoshiko ^{[17
,18
]}

Nakamae, Hirohisa ^{[1
]}

机构：

[1] Osaka Metropolitan Univ, Grad Sch Med, Dept Hematol, Osaka, Japan

[2] Osaka Metropolitan Univ, Grad Sch Med, Dept Prevent Med & Environm Hlth, Osaka, Japan

[3] Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Tokyo, Japan

[4] Kobe City Med Ctr Gen Hosp, Dept Hematol, Kobe, Japan

[5] Osaka Univ, Grad Sch Med, Dept Environm Med & Populat Sci, Suita, Japan

[6] Natl Ctr Global Hlth & Med, Dept Hematol, Tokyo, Japan

[7] Nagasaki Univ Hosp, Transfus & Cell Therapy Unit, Nagasaki, Japan

[8] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Hematol Div, Tokyo, Japan

[9] Nagoya Daiichi Hosp, Japanese Red Cross Aichi Med Ctr, Dept Hematol, Nagoya, Japan

[10] Hokkaido Univ Hosp, Dept Hematol, Sapporo, Japan

[11] Okayama Univ Hosp, Dept Hematol & Oncol, Okayama, Japan

[12] Jichi Med Univ, Saitama Med Ctr, Div Hematol, Saitama, Japan

[13] Univ Tsukuba Hosp, Dept Hematol, Tsukuba, Japan

[14] Anjo Kosei Hosp, Dept Hematol & Oncol, Anjo, Japan

[15] Hamanomachi Hosp, Dept Hematol, Fukuoka, Japan

[16] Natl Canc Ctr, Dept Hematopoiet Stem Cell Transplantat, Tokyo, Japan

[17] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagoya, Japan

[18] Aichi Med Univ, Sch Med, Dept Registry Sci Transplant & Cellular Therapy, Nagakute, Japan

来源：

TRANSPLANTATION AND CELLULAR THERAPY | 2024年 / 30卷 / 03期

关键词：

Myelodysplastic; syndrome; Peripheral blood stem; cell transplantation; Haploidentical donor; Matched unrelated donor; Post-transplantation; cyclophosphamide; BONE-MARROW-TRANSPLANTATION; WORLD-HEALTH-ORGANIZATION; MYELOID NEOPLASMS; ACUTE-LEUKEMIA; TRUMP DATA; IMPACT; CLASSIFICATION; DISPARITY; SURVIVAL; REVISION;

D O I：

10.1016/j.jtct.2023.10.021

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Allogeneic hematopoietic cell transplantation (allo-HCT) is the sole curative therapy for myelodysplastic syndrome (MDS). In the absence of an HLA-matched sibling donor, an HLA-matched unrelated donor (MUD) is considered the leading candidate. However, in recent decades, the alternative donor pool has been extended to HLA-haploidentical donors, especially with the development of graft -versus -host disease (GVHD) prophylaxis using post -transplantation cyclophosphamide (PTCy). Comparative data for haploidentical

引用

页数：12

共 50 条

[1] Risk of Cytomegalovirus Infection with Post-Transplantation Cyclophosphamide in Haploidentical and HLA-Matched Unrelated Donor Transplantation
Jamy, Omer
Hebert, Courtney
Dunn-Valadez, Sydney
Magnusson, Tylan
Watts, Nicole
McGwin, Gerald
Saad, Ayman
[J]. TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (04): : 213.e1 - 213.e6
[2] Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide
McCurdy, Shannon R.
Kasamon, Yvette L.
Kanakry, Christopher G.
Bolanos-Meade, Javier
Tsai, Hua-Ling
Showel, Margaret M.
Kanakry, Jennifer A.
Symons, Heather J.
Gojo, Ivana
Smith, B. Douglas
Bettinotti, Maria R.
Matsui, William H.
Dezern, Amy E.
Huff, Carol Ann
Borrello, Ivan
Pratz, Keith W.
Gladstone, Douglas E.
Swinnen, Lode J.
Brodsky, Robert A.
Levis, Mark J.
Ambinder, Richard F.
Fuchs, Ephraim J.
Rosner, Gary L.
Jones'and, Richard J.
Luznik, Leo
[J]. HAEMATOLOGICA, 2017, 102 (02) : 391 - 400
[3] Peripheral blood stem cell transplantation using HLA-haploidentical donor with post-transplant cyclophosphamide versus HLA-matched sibling donor for lymphoma
Nakaya, Yosuke
Nakamae, Hirohisa
Nishikubo, Masashi
Kondo, Eisei
Fukuda, Takahiro
Hiramoto, Nobuhiro
Mori, Yasuo
Nagafuji, Koji
Eto, Tetsuya
Onishi, Yasushi
Uchida, Naoyuki
Ishikawa, Jun
Matsuoka, Ken-ichi
Yui, Shunsuke
Takase, Ken
Kawakita, Toshiro
Kanda, Junya
Ichinohe, Tatsuo
Atsuta, Yoshiko
Kako, Shinichi
[J]. BONE MARROW TRANSPLANTATION, 2024, 59 (05) : 630 - 636
[4] Peripheral blood stem cell transplantation using HLA-haploidentical donor with post-transplant cyclophosphamide versus HLA-matched sibling donor for lymphoma
Yosuke Nakaya
Hirohisa Nakamae
Masashi Nishikubo
Eisei Kondo
Takahiro Fukuda
Nobuhiro Hiramoto
Yasuo Mori
Koji Nagafuji
Tetsuya Eto
Yasushi Onishi
Naoyuki Uchida
Jun Ishikawa
Ken-ichi Matsuoka
Shunsuke Yui
Ken Takase
Toshiro Kawakita
Junya Kanda
Tatsuo Ichinohe
Yoshiko Atsuta
Shinichi Kako
[J]. Bone Marrow Transplantation, 2024, 59 : 630 - 636
[5] Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow Transplantation
Williams, Louis
Cirrone, Frank
Cole, Kelli
Abdul-Hay, Maher
Luznik, Leo
Al-Homsi, Ahmad Samer
[J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
[6] Post-Transplantation Cyclophosphamide for Prevention of Graft-Versus-Host Disease after HLA-Matched Related and Unrelated Donor Peripheral Blood Stem Cell Transplantation
Miekarek, Marco
Furlong, Terry
O'Donnell, Paul V.
Storer, Barry E.
McCune, Jeannine S.
Storb, Rainer F.
Carpenter, Paul A.
Flowers, Mary E. D.
Appelbaum, Frederick R.
Martin, Paul J.
[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S406 - S406
[7] Impact of Post-Transplantation Cyclophosphamide on Transfusion Requirements in HLA-Matched Sibling Peripheral Blood Stem Cell Transplantation
Marco-Ayala, Javier
Sanz, Jaime
Gomez-Segui, Ines
Balaguer-Rosello, Aitana
Montoro, Juan
Guerreiro, Manuel
Chorao, Pedro
Facal, Ana
Villalba, Marta
Sanz, Miguel Angel
de la Rubia, Javier
Solves, Pilar
[J]. TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (05): : 313.e1 - 313.e10
[8] T-Cell-Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of Contemporaneous HLA-Matched Related and Unrelated Donor Transplantation
Bashey, Asad
Zhang, Xu
Sizemore, Connie A.
Manion, Karen
Brown, Stacey
Holland, H. Kent
Morris, Lawrence E.
Solomon, Scott R.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (10) : 1310 - 1316
[9] Outcomes with HLA-matched unrelated donor versus haploidentical hematopoietic cell transplantation
Mushtaq, Muhammad Umair
Shahzad, Moazzam
Amin, Muhammad K.
Lutfi, Forat
Dejarnette, Shaun
Al-Ramahi, Joe S.
Li, Kevin
Ahmed, Nausheen
Bansal, Rajat
Abdelhakim, Haitham
Shune, Leyla
Abdallah, Al-Ola
Abhyankar, Sunil H.
Mcguirk, Joseph P.
Singh, Anurag K.
[J]. LEUKEMIA & LYMPHOMA, 2024, 65 (04) : 493 - 502
[10] Haploidentical versus Matched Unrelated versus Matched Sibling Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide
Mehta, Rohtesh S.
Saliba, Rima M.
Ghanem, Sassine
Alousi, Amin M.
Rondon, Gabriela
Anderlini, Paolo
Al-Atrash, Gheath
Bashir, Qaiser
Hosing, Chitra M.
Im, Jin S.
Kebriaei, Partow
Khouri, Issa
Marin, David
Nieto, Yago
Olson, Amanda
Oran, Betul
Popat, Uday R.
Qazilbash, Muzaffar H.
Ramdial, Jeremy
Saini, Neeraj
Srour, Samer A.
Champlin, Richard E.
Rezvani, Katayoun
Shpall, Elizabeth J.
[J]. TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (07): : 395.e1 - 395.e11

← 1 2 3 4 5 →